Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.

Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.

Publication date: Apr 01, 2024

Concepts Keywords
Confounders COVID-19
Covid Critically ill
Safe Direct thrombin inhibitor
Thromboplastin Intensive care unit
SARS-CoV2

Semantics

Type Source Name
drug DRUGBANK Argatroban
disease VO effective
drug DRUGBANK Thrombin
disease VO time
disease IDO assay
drug DRUGBANK Heparin
disease MESH COVID-19
disease MESH acute respiratory distress syndrome
disease MESH bleeding
disease MESH death
disease MESH thromboembolism
disease MESH Critically ill

Original Article

(Visited 1 times, 1 visits today)